Notice
Record an episode in your own words: what happened, its effect on your day, and the context you want to remember.
Your autoimmune observation journal
Living with an autoimmune condition can mean a lot to remember. SteadyLens brings your episodes, things tried, reliable information, and care questions together so you can bring clearer context to your next doctor visit.

Record an episode in your own words: what happened, its effect on your day, and the context you want to remember.
Revisit things tried and later observations. Missing days stay unknown, and a later change does not establish a cause.
Choose your episodes, approaches, and questions. Read and review your visit brief before sharing it yourself.
Inside SteadyLens
These are the current app workflows. The product is still in development; availability depends on the reviewed release.
Record dates, timing, duration, daily impact, optional fatigue and pain ratings, what you tried, and what you noticed afterward. Leave unknown details blank.
Read and revisit your episodes with their context. A day without an entry does not become a symptom-free day.
Keep personal routines, reported clinician-guided changes, and research-study participation distinct. Note dates, your goal, what you did, and later observations.
Open official MedlinePlus autoimmune information, ClinicalTrials.gov, and study basics. No journal details or automatic condition query are sent in these links; the study team determines eligibility.
Keep questions for your doctor, choose a date range and what to include, then read a structured brief. Changes require a fresh review before export.
Native development uses an encrypted on-device journal. Failed saves keep drafts for retry. Review, export, and erase remain available when paid logging is unavailable.
A closer look
Choose what matters for your visit, then review the brief before sharing. Fictional development example.
Screens show fictional sample entries from the current development preview. The browser preview is not the native app's encrypted storage.

Planned access
Planned U.S. Plus pricing is $3.99 per month or $39.99 per year. Store setup is pending; purchases are not available yet. Apple or Google will confirm eligible trial access, localized prices, and automatic renewal unless canceled at checkout.
An eligible seven-day store-managed trial is planned for episode and things-tried creation and editing. The store determines eligibility and shows the renewal date and terms. Cancel in store settings before renewal to avoid the next charge. There is no Focalward account trial.
Subscribe to continue logging after your free trial, with access to the same saved history.
| Feature | Without a subscription | Plus trial or subscription |
|---|---|---|
| Onboarding and saved record review | Included | Included |
| Create or edit episodes and things tried | Not included | Included |
| Questions and reliable resource links | Included | Included |
| Visit selection, reviewed brief, and export | Included | Included |
| Delete entries or erase the local journal | Included | Included |
| Cloud sync, recovery, and AI analysis | Not available | Not available |
Always available without a subscription: Saved records, questions, visit selection and reviewed export, and deletion remain available without a subscription. This website does not start a trial or purchase.
Private by design
The native development journal is encrypted on your device with a device-only key. No account is required, and there is no cloud sync, cloud recovery, or AI analysis. You review and choose what to share. Losing the device or encryption key can mean losing your records. Browser previews contain unencrypted fictional samples only.
SteadyLens does not diagnose, predict flares, recommend treatment or doses, or establish causes or treatment effects. Research resources do not determine your eligibility or enroll you in a study.
Resources
In development. SteadyLens is not yet available in app stores, and a public beta is not open. Availability and release details will be announced when ready.